Gain full access to the latest clinical content available from Springer Nature
06-16-2017 | Video
STAMPEDE trial changes standard of care
Nicholas James discusses the STAMPEDE trial results supporting use of abiraterone in advanced prostate cancer patients beginning long-term androgen deprivation therapy.
Latest from across the site
07-25-2017 | Epidemiology | News
Holocaust survivors at increased risk for cancer
Holocaust survivors have a small but significant increased risk for cancer, show findings of a study comparing individuals who were entitled to compensation for suffering persecution during the war with individuals denied such compensation.
Cancer 2017; Advance online publication
07-20-2017 | Epidemiology | News
Rare cancer rates measured in Europe
Nearly a quarter of all cancers diagnosed in the European Union between 2000 and 2007 were classed as rare, according to updated epidemiologic information from the Information Network on Rare Cancers.
Lancet Oncol 2017; Advance online publication
07-19-2017 | Breast cancer | News
Genetic test identifies ultralow-risk breast cancers
The 70-gene MammaPrint assay can identify women who have an ultralow risk for death from breast cancer in the long term, potentially allowing their physicians to choose less aggressive treatment, say researchers.
JAMA Oncol 2017; Advance online publication
Neuer Inhalt, STAMPEDE image, New Content Item, Anas Younes, Matti Aapro, Ricardo Alvarez, New Content Item, Ross Camidge, Paolo G. Casali, Javier Cortes, Beth Eaby-Sandy, Axel Merseburger, Emili Montserrat, Paul Nathan, Adam Riker, L Sequist, Krishnansu S Tewari, Xavier Thomas, Michael Weller, Jasmine Zain